New eczema Cream's pregnancy safety under investigation
NCT ID NCT06627335
Summary
This study looks at pregnancy outcomes for women with eczema who used ruxolitinib cream during pregnancy compared to those who used standard steroid creams. Researchers will analyze health insurance claims data from over 5,600 women to check for birth defects and other pregnancy complications. The goal is to understand whether this newer eczema treatment is safe for use during pregnancy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Syneos Health (remote site)
RECRUITINGMorrisville, North Carolina, 27560, United States
Conditions
Explore the condition pages connected to this study.